CIS Pharma offers a platform of different eye drop dispenser technologies designed for preservative-free drug formulations as eye-drops or as a spray. Devices to control eye-lids as well as digital technology to monitor drug dispense are available to improve the compliance of patients. The platform is a result of our expertise in ophthalmology: since the early eighties CIS Pharma has developed and licensed a number of drug substances for and to market leaders in ophthalmology. Our client’s drug products and respective dispensers have changed dramatically over that time.
The industry has seen significant improvements both in formulations as well as in new dispenser technology for such drugs. Today, preservative-free formulations improve the safety of chronically used drugs such as in glaucoma. Initially, the unpreserved formulations were offered in mono-doses for single-use, today multi-dose preservative-free products take over significant market share as a more economical solution with improved usability. At CIS Pharma, we also include digital technology such as sensors, databases and apps, to monitor drug intake and patient compliance. Very valuable information is derived from these digital processes, both during the clinical development as well as for drugs marketed.
CIS Pharma’s multi-dosing delivery platform is offering precise dosing of solutions from low to high viscosities. The fill volume is variable and the dispensed products may be delivered as a drop or as a stream. Furthermore, we offer an anti-microbial tip design reducing 5-log of colony forming units (CFU) within 1-2 hours, ensuring safety between each application.